Last reviewed: May 15, 2026
Last updated: May 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Henry Meds is a telehealth platform that connects patients with licensed medical providers for GLP-1 prescriptions. The platform has gained attention in the weight-management space, with reports suggesting it serves thousands of patients seeking remote access to semaglutide and tirzepatide. Understanding Henry Meds' clinical credentialing, pharmacy sourcing, and pricing model is essential for patients evaluating telehealth GLP-1 options.
Telehealth providers like Henry Meds address a real gap: access to weight-management medications without in-person visits. However, patients should distinguish between the telehealth consultation model and the actual medication source. PlexusDx emphasizes precision-wellness through genetic screening and licensed 503A compounding—complementary approaches to understanding which patient may benefit from specific GLP-1 compounds based on predispositions in peptide pathways.
What Henry Meds Offers and How It Operates
Henry Meds operates as a digital health platform connecting patients to board-certified or board-eligible physicians for telehealth consultations. The service focuses on weight management and metabolic conditions, offering prescription pathways for GLP-1 receptor agonists. Initial consultations are typically video-based, with follow-up care coordinated remotely. The platform handles prescription fulfillment through partner pharmacies.
The Henry Meds model relies on streamlined patient intake and provider matching. Patients complete health questionnaires, speak with a provider, and receive prescriptions if deemed appropriate. Pricing varies by medication strength and supply length. Henry Meds does not manufacture medications directly; prescriptions are filled through pharmacy partners, which may source branded or compounded formulations depending on availability and patient insurance.
Provider Credentialing and Clinical Standards Comparison
Henry Meds emphasizes provider credentialing—physicians on the platform are required to hold active medical licenses and maintain malpractice insurance. The platform conducts background verification and credential checks. However, patients should verify individual provider qualifications, as telehealth platforms vary in the depth of subspecialty training or obesity-medicine certification among their networks.
Comparing Henry Meds to direct compounding pharmacy models reveals different risk and oversight structures. Telehealth platforms like Henry Meds center on physician-patient interaction and prescription authority. Compounding pharmacy models, such as PlexusDx, center on pharmacy credentialing (503A vs. 503B designation) and direct relationships between patients and licensed pharmacists who prepare medications.
| Aspect |
Henry Meds (Telehealth Model) |
Direct Compounding Pharmacy Model |
| Primary Credentialing |
Physician license and malpractice insurance verification |
Licensed 503A compounding pharmacy permit and state board oversight |
| Medication Source |
Partner pharmacies (branded or compounded, varies) |
In-house compounding from pharmaceutical-grade ingredients |
| Personalization Tool |
Standard medical history intake |
Optional genetic screening for peptide pathway predispositions |
| Cost Range (Monthly) |
Typically $129-$369/mo+ depending on medication |
Compounded semaglutide $149; tirzepatide $249 |
| Follow-up Care |
Remote provider check-ins on platform |
Pharmacist consultation plus optional genetic test ($99 add-on or $298 standalone) |
Pharmacy Standards: Branded vs. Compounded Sourcing
Henry Meds' pharmacy partners may dispense branded medications (Ozempic, Mounjaro, Wegovy, Zepbound) or compounded versions depending on insurance coverage, availability, and cost. Branded GLP-1s are FDA-approved and manufactured under strict facility standards. Compounded medications are not FDA-approved but are prepared by licensed pharmacies under state and federal oversight, with quality expectations set by the U.S. Pharmacopeia (USP) and state boards.
Patients using Henry Meds should ask their assigned pharmacy whether the sourced medication is branded or compounded, as this affects cost, supply chain, and any applicable insurance reimbursement. Compounded versions may cost less out-of-pocket but may not be covered by all plans. PlexusDx exclusively partners with licensed 503A compounding pharmacies—never 503B facilities—to maintain direct pharmacy oversight and consistent quality standards across all medication preparations.
Clinical Considerations: Who Benefits and When to Escalate
Henry Meds may be suitable for patients seeking convenient telehealth access to GLP-1s without in-person clinic visits, particularly those with stable baseline health and no complex medical histories. Patients with well-managed hypertension, diabetes, or cardiovascular disease may use the platform if their provider performs appropriate screening. However, telehealth consultations have inherent limits in physical examination and dynamic clinical assessment compared to in-person care.
Escalation to specialist or in-person care is warranted if a patient reports symptoms of pancreatitis, significant gastrointestinal side effects, rapid heart rate changes, or signs of dehydration. Henry Meds providers may refer such cases to emergency care or local clinicians. Patients with complicated medical histories, kidney disease, or ongoing psychiatric medication management may benefit from hybrid care—combining telehealth convenience with periodic in-person evaluation from their primary care team.
Safety, Eligibility, and Informed Decision-Making
Henry Meds conducts basic medical screening to exclude high-risk patients (e.g., those with personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe renal impairment). However, patients must disclose all relevant medical history accurately. Common reasons for ineligibility include active pregnancy, uncontrolled type 1 diabetes, or recent bariatric surgery. Always inform your Henry Meds provider of all medications, supplements, and prior adverse reactions.
Before choosing Henry Meds or any GLP-1 provider, understand the full cost structure, medication source, and follow-up plan. Request details on how side effects are managed, what happens if the medication is discontinued, and whether genetic or biomarker testing is offered. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on or $298 standalone) to help provide context on peptide pathway predispositions—a complementary assessment that can support conversations with any prescriber, including those using telehealth platforms.
How PlexusDx Supports a More Personalized Approach
Genetic predispositions in GLP-1 receptor signaling, GIPR pathways, and metabolic genes (such as FTO and MC4R variants) may provide context for why some patients experience better appetite suppression or weight loss with specific GLP-1 formulations. A patient's genetic profile does not dictate which medication will work, but it can help inform a more informed discussion with a healthcare provider about personalized dosing or compound selection.
PlexusDx's Precision Peptide Genetic Test analyzes key variants (GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, MC4R rs17782313) and reports findings on predispositions in peptide genetic pathways. This test is designed to complement—not replace—medical evaluation. Results should be interpreted by a qualified healthcare provider and may help contextualize why certain dosing strategies or formulation choices might be relevant for your metabolic profile.
Whether you choose Henry Meds, a local weight-management clinic, or PlexusDx's compounding model, discussing your genetic screening results and metabolic history with your prescriber can support a more personalized treatment plan. PlexusDx integrates genetic insight with licensed 503A compounding to help bridge the gap between telehealth convenience and precision-wellness decision-making.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Henry Meds a licensed medical provider?
Henry Meds is a telehealth platform that connects patients with licensed physicians and nurse practitioners. Individual providers maintain valid state medical licenses and malpractice insurance. Always verify your assigned provider's credentials through your state medical board.
Does Henry Meds use compounded or branded GLP-1 medications?
Henry Meds' pharmacy partners may source either branded (FDA-approved) or compounded GLP-1 medications, depending on insurance, cost, and availability. Ask your pharmacy which formulation you are receiving and confirm whether it is covered by your plan.
How does Henry Meds pricing compare to PlexusDx compounding options?
Henry Meds typically ranges $129-$369/mo+ monthly depending on medication and dose. PlexusDx compounded semaglutide costs $149/mo and tirzepatide $249/mo from licensed 503A pharmacies, often with direct price transparency and optional genetic screening.
What happens if I experience side effects with Henry Meds?
Contact your Henry Meds provider immediately through the platform's messaging or scheduled appointment. Severe symptoms (chest pain, difficulty breathing, severe nausea) require emergency care. Your provider can adjust dosing, pause treatment, or refer you to specialist care.
Can genetic testing help me choose between Henry Meds and other GLP-1 options?
The PlexusDx Precision Peptide Genetic Test may provide context on peptide pathway predispositions ($99 add-on or $298 standalone). Results should be discussed with your prescriber—whether at Henry Meds or elsewhere—to support a more informed treatment conversation.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
LillyDirect Tirzepatide: Access, Eligibility, and Personalized Prescribing Options
Henry Meds Reviews: Clinical Efficacy, Genetic Screening & Provider Selection